Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.
Press releases published on April 24, 2025
Mitolyn Reviews 2025: Why This Non-Stimulant Best Weight Loss Supplement Is a Game-Changer for Fat Burn and Metabolism
GlobeNewswire
·
April 24, 2025
Tallmadge, Ohio, April 24, 2025 (GLOBE NEWSWIRE) -- As more health-conscious individuals seek safer, stimulant-free alternatives for weight management in 2025, natural supplements are becoming the gold standard. Crash diets, intense fitness programs, and …
CRB Appoints Ken Olson as Chief Financial Officer
GlobeNewswire
·
April 24, 2025
Kansas City, Missouri, April 24, 2025 (GLOBE NEWSWIRE) -- CRB, a leading global provider of sustainable engineering, architecture, construction and consulting solutions to the life sciences and food and beverage industries, today announced the appointment …
The Joint Corp. to Host Conference Call on Thursday, May 8th to Discuss First Quarter 2025 Results
GlobeNewswire
·
April 24, 2025
SCOTTSDALE, Ariz., April 24, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) a national operator, manager, and franchisor of chiropractic clinics, announced it will report its first quarter 2025 financial results on Thursday, May 8, 2025, after the …
Pasithea Therapeutics to Present Updated Data from Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients at the 2025 ASCO Annual Meeting
GlobeNewswire
·
April 24, 2025
MIAMI, April 24, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of …
EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting
GlobeNewswire
·
April 24, 2025
Focal One i expands HIFUsion® patient-specific imaging compatibility to include PSMA PET, ExactVu™ Micro-Ultrasound, along with AI-driven and intelligent algorithms including Unfold AI™ and OnQ™ Prostate Focal One i extends HIFUsion capabilities to …
Ligand to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 24, 2025
JUPITER, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report first quarter 2025 financial results before the opening of the U.S. financial markets on Thursday, May 8, 2025. The …
Kymera Therapeutics to Unveil New Oral Immunology Program and Report First Quarter 2025 Financial Results on May 9, 2025
GlobeNewswire
·
April 24, 2025
Watertown, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that it …
Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision
GlobeNewswire
·
April 24, 2025
WHO WHAT WHERE WHEN WHY Nuwellis, Inc. Issuance of U.S. Patent No. 12,280,007. United States Patent and Trademark Office April 22, 2025 To protect a novel self-emptying fluid bag design that improves nursing workflow while maintaining system accuracy. …
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
GlobeNewswire
·
April 24, 2025
SAN JOSE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited …
Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025
GlobeNewswire
·
April 24, 2025
Expanded suite of consumables, instruments and services designed to empower researchers and accelerate next-generation drug development Ninety posters and presentations at AACR powered by the Standard BioTools proteomic portfolio to advance cancer research …
BioNTech präsentiert auf der AACR-Jahrestagung 2025 klinische und präklinische Daten zu mRNA- und Immunonkologie-Fokus-Programmen
GlobeNewswire
·
April 24, 2025
MAINZ, Deutschland, 24. April 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird auf der diesjährigen Jahrestagung der American Association for Cancer Research („AACR“), die vom 25. bis 30. April 2025 in Chicago, …
Best Oral Steroid for Strength in 2025: Top Steroids for Bodybuilding, Cutting, Muscle Growth & Raw Power (By Crazy Bulk)
GlobeNewswire
·
April 24, 2025
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- The best oral steroids aren’t just about size — they’re about performance, power, and pushing your body beyond its current limits. Whether you're a powerlifter aiming for new PRs, a CrossFit athlete chasing …
ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225
GlobeNewswire
·
April 24, 2025
Garching / Munich, Germany and VANCOUVER, British Columbia, April 24, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Alpha-9 Oncology (Alpha-9), a clinical-stage biotechnology company advancing a …
Orion Oyj:n nimitysvaliokunnan kokoonpano
GlobeNewswire
·
April 24, 2025
ORION OYJ PÖRSSITIEDOTE – MUUT PÖRSSIN SÄÄNTÖJEN NOJALLA JULKISTETTAVAT TIEDOT 24.4.2025 KLO 11.00 Orion Oyj:n nimitysvaliokunnan kokoonpano Orion Oyj:n hallitus on nimittänyt yhtiön nimitysvaliokunnan jäseniksi seuraavat henkilöt: …
ProDentim Reviews (Ingredients, Complaints & Side Effects) 2025 – Honest User Feedback on Dental Benefits and Real Results
GlobeNewswire
·
April 24, 2025
TALLMADGE, Ohio, April 24, 2025 (GLOBE NEWSWIRE) -- In the ever-evolving world of dental care, ProDentim has quickly gained attention as a game-changing supplement, offering a fresh take on how we support oral health. As buzz continues to grow, so does …
iSTAR Medical’s MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial
GlobeNewswire
·
April 24, 2025
For immediate release iSTAR Medical’s MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial Five-year safety profile including corneal health confirmed and 38% IOP reduction sustained Over 5000 patients …
Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients
GlobeNewswire
·
April 24, 2025
Primary endpoint met, no drug-related serious adverse events Positive hematoma and edema volume evolution Recruitment stopped early due to positive exploratory and efficacy outcomes Preparations underway to initiate Phase 2b study Gosselies, Belgium, 24 …
Bioxodes annonce des données intermédiaires positives pour son essai de phase 2a portant sur BIOX-101 dans le traitement de l’AVC hémorragique
GlobeNewswire
·
April 24, 2025
Le critère d’évaluation principal a été atteint, aucun événement indésirable grave associé au médicament n’a été rapporté L’évolution du volume de l’hématome et de l’œdème est favorable Le recrutement des patients a été arrêté plus tôt que prévu en raison …
Late-breaking elafibranor primary sclerosing cholangitis (PSC) data demonstrates favorable safety profile and significant efficacy in second potential rare liver disease indication
GlobeNewswire
·
April 24, 2025
Elafibranor showed a favorable safety profile and demonstrated dose-dependent efficacy over 12 weeks for people living with PSC, a rare liver disease that currently has no approved treatment options Patients treated with elafibranor versus placebo showed …
Press Release: Sanofi: strong Q1 performance and 2025 guidance confirmed
GlobeNewswire
·
April 24, 2025
Sanofi: strong Q1 performance and 2025 guidance confirmed Paris, April 24, 2025 Q1 sales growth of 9.7% at CER1 and business EPS2 of €1.79 Pharma launches reached sales of €0.8 billion, up 43.8%, driven by ALTUVIIIO Dupixent sales were €3.5 billion, up 20. …